Key result
IntraValvular Impedance (IVI) sensing is feasible on biological heart valves, with the greatest sensitivity observed using small electrodes embedded in the valve commissures.
Why the study?
Without routine imaging surveillance, subclinical valve thrombosis characterized by progressive reduction in leaflet motion may be underdiagnosed.
Embedding miniaturized electrodes in biological heart valves for intravalvular impedance sensing is feasible in vitro and could potentially allow early detection of subclinical valve thrombosis.
IVI sensing on bioprostheses remains experimental; leaves open electrode optimization for future integrated valve monitoring.
Subclinical valve thrombosis in heart valve prostheses is characterized by the progressive reduction in leaflet motion detectable with advanced imaging diagnostics. However, without routine imaging surveillance, this subclinical thrombosis may be underdiagnosed. We recently proposed the novel concept of a sensorized heart valve prosthesis based on electrical impedance measurement (IntraValvular Impedance, IVI) using miniaturized electrodes embedded in the valve structure to generate a local electric field that is altered by the cyclic movement of the leaflets. In this study, we investigated the feasibility of the novel IVI-sensing concept applied to biological heart valves (BHVs). Three proof-of-concept prototypes of sensorized BHVs were assembled with different size, geometry and positioning of the electrodes to identify the optimal IVI-measurement configuration. Each prototype was tested in vitro on a hydrodynamic heart valve assessment platform. IVI signal was closely related to the electrodes' positioning in the valve structure and showed greater sensitivity in the prototype with small electrodes embedded in the valve commissures. The novel concept of IVI sensing is feasible on BHVs and has great potential for monitoring the valve condition after implant, allowing for early detection of subclinical valve thrombosis and timely selection of an appropriate anticoagulation therapy.
No takes yet. Share an insight, caveat, or question.
Gironi et al. (2022) studied Subclinical valve thrombosis in heart valve prostheses (n=3). IntraValvular Impedance (IVI) sensing was evaluated on Feasibility and optimal IVI-measurement configuration. IntraValvular Impedance (IVI) sensing is feasible on biological heart valves, with the greatest sensitivity observed using small electrodes embedded in the valve commissures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: